Kriya Therapeutics, Inc.

New Filing

CIK: 0001811209·Biotechnology·DELAWARE·Filed: May 19, 2020

Total Offering

$85,634,918

Amount Sold

$85,634,886

Investors

20

First Sale

May 4, 2020

Offering Details

Type: Equity, Option to Acquire, Security to be Acquired
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2019
Non-Accredited Investors: No

Related Persons

Name	Role
Shankar Ramaswamy	Related Person
Roger Jeffs	Related Person
C.R. Sincock	Related Person
Ilan Oren	Related Person
Keith Manchester	Related Person

Company

Kriya Therapeutics, Inc.

3000 EL CAMINO REAL

PALO ALTO, CA, 94306

(833) 574-9289

SEC Filing

0001811209-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.